P-cadherin is coexpressed with CD44 and CD49f and mediates stem cell properties in basal-like breast cancer

Stem Cells

Volumn 30, Issue 5, 2012, Pages 854-864

  Vieira, André Filipe ^a,b   Ricardo, Sara ^a   Ablett, Matthew Paul ^b   Dionísio, Maria Rita ^a,c   Mendes, Nuno ^a   Albergaria, André ^a   Farnie, Gillian ^b   Gerhard, Renê ^a   Cameselle Teijeiro, Jorge F ^d   Seruca, Raquel ^a,e   Schmitt, Fernando ^a,e   Clarke, Robert B ^b   Paredes, Joana ^a,e  

^a UNIVERSITY OF PORTO   (Portugal)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

^c Gulbenkian Programme for Advanced Medical Education   (Spain)

^d UNIVERSITY HOSPITAL COMPLEX OF VIGO   (Spain)

^e University of Porto   (Portugal)

Author keywords

Basal like breast cancer; Biomarker; Cancer stem cells; CDH3 gene; P cadherin

Indexed keywords

ALDEHYDE DEHYDROGENASE; ALDEHYDE DEHYDROGENASE ISOENZYME 1; ALPHA6 INTEGRIN; HERMES ANTIGEN; P CADHERIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BASAL LIKE BREAST CARCINOMA; BREAST CARCINOMA; CANCER GRADING; CANCER GROWTH; CANCER PROGNOSIS; CANCER SIZE; CANCER SURVIVAL; CARCINOGENICITY; CELL DEATH; CELL RENEWAL; COLONY FORMATION; CONTROLLED STUDY; CYTOPLASM; DISEASE ASSOCIATION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPH NODE; MOUSE; NONHUMAN; PHENOTYPE; PROTEIN EXPRESSION; RADIOSENSITIVITY; STEM CELL; X IRRADIATION;

ANTIGENS, CD44; BREAST NEOPLASMS; CADHERINS; CELL DEATH; CELL LINE, TUMOR; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTEGRIN ALPHA6; ISOENZYMES; NEOPLASM PROTEINS; NEOPLASMS, BASAL CELL; NEOPLASTIC STEM CELLS; RETINAL DEHYDROGENASE; X-RAYS;

EID: 84860499799     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1002/stem.1075     Document Type: Article

References (62)

1. Reya T, Morrison SJ, Clarke MF et al. Stem cells, cancer, and cancer stem cells. Nature 2001;414:105-111. (Pubitemid 33041634)
2. Li X, Lewis MT, Huang J et al. Intrinsic resistance of tumorigenic breast cancer cells to chemotherapy. J Natl Cancer Inst 2008;100: 672-679.
3. Phillips TM, McBride WH, Pajonk F. The response of CD24(-/low)/CD44+ breast cancer-initiating cells to radiation. J Natl Cancer Inst 2006;98:1777-1785. (Pubitemid 46017929)
4. Charafe-Jauffret E, Ginestier C, Birnbaum D. Breast cancer stem cells: Tools and models to rely on. BMC Cancer 2009;9: 202.
5. Al-Hajj M, Wicha MS, Benito-Hernandez A et al. Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA 2003;100:3983-3988. (Pubitemid 36418143)
6. Meyer MJ, Fleming JM, Lin AF et al. CD44posCD49fhiCD133/2hi defines xenograft-initiating cells in estrogen receptor-negative breast cancer. Cancer Res 2010;70:4624-4633.
7. Wright MH, Calcagno AM, Salcido CD et al. Brca1 breast tumors contain distinct CD44+/CD24- and CD133+ cells with cancer stem cell characteristics. Breast Cancer Res 2008;10:R10.
8. Hwang-Verslues WW, Kuo WH, Chang PH et al. Multiple lineages of human breast cancer stem/progenitor cells identified by profiling with stem cell markers. PLoS One 2009;4:e8377.
9. Lim E, Vaillant F, Wu D et al. Aberrant luminal progenitors as the candidate target population for basal tumor development in BRCA1 mutation carriers. Nat Med 2009;15:907-913.
10. Molyneux G, Geyer FC, Magnay FA et al. BRCA1 basal-like breast cancers originate from luminal epithelial progenitors and not from basal stem cells. Cell Stem Cell 2010;7:403-417.
11. Liu S, Ginestier C, Charafe-Jauffret E et al. BRCA1 regulates human mammary stem/progenitor cell fate. Proc Natl Acad Sci USA 2008; 105:1680-1685. (Pubitemid 351346574)
12. Gorski JJ, James CR, Quinn JE et al. BRCA1 transcriptionally regulates genes associated with the basal-like phenotype in breast cancer. Breast Cancer Res Treat. 2010;122:721-731.
13. Matos I, Dufloth R, Alvarenga M et al. p63, cytokeratin 5, and P-cadherin: Three molecular markers to distinguish basal phenotype in breast carcinomas. Virchows Arch 2005;447:688-694. (Pubitemid 41571183)
14. Paredes J, Albergaria A, Oliveira JT et al. P-cadherin overexpression is an indicator of clinical outcome in invasive breast carcinomas and is associated with CDH3 promoter hypomethylation. Clin Cancer Res 2005;11:5869-5877. (Pubitemid 41170315)
15. Paredes J, Milanezi F, Viegas L et al. P-cadherin expression is associated with high-grade ductal carcinoma in situ of the breast. Virchows Arch 2002;440:16-21. (Pubitemid 34143345)
16. Ribeiro AS, Albergaria A, Sousa B et al. Extracellular cleavage and shedding of P-cadherin: A mechanism underlying the invasive behaviour of breast cancer cells. Oncogene 2010;29:392-402.
17. Albergaria A, Ribeiro AS, Vieira AF et al. P-cadherin role in normal breast development and cancer. Int J Dev Biol 2011;55:811-822.
18. Radice GL, Ferreira-Cornwell MC, Robinson SD et al. Precocious mammary gland development in P-cadherin-deficient mice. J Cell Biol 1997;139:1025-1032. (Pubitemid 27508572)
19. Hirai Y, Nose A, Kobayashi S et al. Expression and role of E- and P-cadherin adhesion molecules in embryonic histogenesis. I. Lung epithelial morphogenesis. Development 1989;105:263-270. (Pubitemid 19053275)
20. Kolle G, Ho M, Zhou Q et al. Identification of human embryonic stem cell surface markers by combined membrane-polysome translation state array analysis and immunotranscriptional profiling. Stem Cells 2009;27:2446-2456.
21. Rhee H, Polak L, Fuchs E. Lhx2 maintains stem cell character in hair follicles. Science 2006;312:1946-1949. (Pubitemid 43993720)
22. Faraldo MM, Teuliere J, Deugnier MA et al. beta-Catenin regulates P-cadherin expression in mammary basal epithelial cells. FEBS Lett 2007;581:831-836. (Pubitemid 46282713)
23. Shimomura Y, Wajid M, Shapiro L et al. P-cadherin is a p63 target gene with a crucial role in the developing human limb bud and hair follicle. Development 2008;135:743-753. (Pubitemid 351405027)
24. Albergaria A, Ribeiro AS, Pinho S et al. ICI 182,780 induces P-cadherin overexpression in breast cancer cells through chromatin remodelling at the promoter level: A role for C/EBPbeta in CDH3 gene activation. Hum Mol Genet 2010;19:2554-2566.
25. Daniel CW, Strickland P, Friedmann Y. Expression and functional role of E- and P-cadherins in mouse mammary ductal morphogenesis and growth. Dev Biol 1995;169:511-519.
26. Knudsen KA, Wheelock MJ. Cadherins and the mammary gland. J Cell Biochem 2005;95:488-496. (Pubitemid 41420179)
27. Paredes J, Milanezi F, Reis-Filho JS et al. Aberrant P-cadherin expression: Is it associated with estrogen-independent growth in breast cancer? Pathol Res Pract 2002;198:795-801. (Pubitemid 36221701)
28. Paredes J, Stove C, Stove V et al. P-cadherin is up-regulated by the antiestrogen ICI 182,780 and promotes invasion of human breast cancer cells. Cancer Res 2004;64:8309-8317. (Pubitemid 39491769)
29. Ricardo S, Vieira AF, Gerhard R et al. Breast cancer stem cell markers CD44, CD24 and ALDH1: Expression distribution within intrinsic molecular subtype. J Clin Pathol 2011;64:937-946.
30. Deng S, Yang X, Lassus H et al. Distinct expression levels and patterns of stem cell marker, aldehyde dehydrogenase isoform 1 (ALDH1), in human epithelial cancers. PLoS One 2010;5:e10277.
31. Ginestier C, Hur MH, Charafe-Jauffret E et al. ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. Cell Stem Cell 2007;1:555-567. (Pubitemid 350056407)
32. Kenny PA, Lee GY, Myers CA et al. The morphologies of breast cancer cell lines in three-dimensional assays correlate with their profiles of gene expression. Mol Oncol 2007;1:84-96. (Pubitemid 46776616)
33. Paredes J, Lopes N, Milanezi F et al. P-cadherin and cytokeratin 5: Useful adjunct markers to distinguish basal-like ductal carcinomas in situ. Virchows Arch 2007;450:73-80. (Pubitemid 46360747)
34. Charafe-Jauffret E, Ginestier C, Monville F et al. Gene expression profiling of breast cell lines identifies potential new basal markers. Oncogene 2006;25:2273-2284.
35. Neve RM, Chin K, Fridlyand J et al. A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes. Cancer Cell 2006;10:515-527. (Pubitemid 44854747)
36. Fillmore CM, Kuperwasser C. Human breast cancer cell lines contain stem-like cells that self-renew, give rise to phenotypically diverse progeny and survive chemotherapy. Breast Cancer Res 2008;10:R25.
37. Olsson E, Honeth G, Bendahl PO et al. CD44 isoforms are heterogeneously expressed in breast cancer and correlate with tumor subtypes and cancer stem cell markers. BMC Cancer 2011;11:418.
38. Sheridan C, Kishimoto H, Fuchs RK et al. CD44+/CD24- breast cancer cells exhibit enhanced invasive properties: An early step necessary for metastasis. Breast Cancer Res 2006;8:R59.
39. Yoon CS, Kim KD, Park SN et al. Alpha(6) integrin is the main receptor of human papillomavirus type 16 VLP. Biochem Biophys Res Commun 2001;283:668-673.
40. Shackleton M, Vaillant F, Simpson KJ et al. Generation of a functional mammary gland from a single stem cell. Nature 2006;439:84-88. (Pubitemid 43053633)
41. Stingl J, Eirew P, Ricketson I et al. Purification and unique properties of mammary epithelial stem cells. Nature 2006;439:993-997. (Pubitemid 43292419)
42. Burga LN, Hu H, Juvekar A et al. Loss of BRCA1 leads to an increase in epidermal growth factor receptor expression in mammary epithelial cells, and epidermal growth factor receptor inhibition prevents estrogen receptor-negative cancers in BRCA1-mutant mice. Breast Cancer Res 2011;13:R30.
43. Marcato P, Dean CA, Pan D et al. Aldehyde dehydrogenase activity of breast cancer stem cells is primarily due to isoform ALDH1A3 and its expression is predictive of metastasis. Stem Cells 2011;29:32-45.
44. Cariati M, Naderi A, Brown JP et al. Alpha-6 integrin is necessary for the tumourigenicity of a stem cell-like subpopulation within the MCF7 breast cancer cell line. Int J Cancer 2008;122:298-304. (Pubitemid 350234715)
45. Vassilopoulos A, Wang RH, Petrovas C et al. Identification and characterization of cancer initiating cells from BRCA1 related mammary tumors using markers for normal mammary stem cells. Int J Biol Sci 2008;4:133-142. (Pubitemid 351872048)
46. Keller PJ, Arendt LM, Skibinski A et al. Defining the cellular precursors to human breast cancer. Proc Natl Acad Sci USA. 2012;109:2772-2777.
47. Keller PJ, Lin AF, Arendt LM et al. Mapping the cellular and molecular heterogeneity of normal and malignant breast tissues and cultured cell lines. Breast Cancer Res 2010;12:R87.
48. Mani SA, Guo W, Liao MJ et al. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 2008;133: 704-715. (Pubitemid 351636299)
49. Raouf A, Zhao Y, To K et al. Transcriptome analysis of the normal human mammary cell commitment and differentiation process. Cell Stem Cell 2008;3:109-118.
50. Meyer MJ, Fleming JM, Ali MA et al. Dynamic regulation of CD24 and the invasive, CD44posCD24neg phenotype in breast cancer cell lines. Breast Cancer Res 2009;11:R82.
51. Rappa G, Lorico A. Phenotypic characterization of mammosphere-forming cells from the human MA-11 breast carcinoma cell line. Exp Cell Res 2010;316:1576-1586.
52. Visvader JE. Keeping abreast of the mammary epithelial hierarchy and breast tumorigenesis. Genes Dev 2009;23:2563-2577.
53. Shipitsin M, Campbell LL, Argani P et al. Molecular definition of breast tumor heterogeneity. Cancer Cell 2007;11:259-273. (Pubitemid 46349843)
54. Eirew P, Stingl J, Raouf A et al. A method for quantifying normal human mammary epithelial stem cells with in vivo regenerative ability. Nat Med 2008;14:1384-1389.
55. Stingl J, Eaves CJ, Zandieh I et al. Characterization of bipotent mammary epithelial progenitor cells in normal adult human breast tissue. Breast Cancer Res Treat 2001;67:93-109. (Pubitemid 32744490)
56. Rakha E, Reis-Filho JS. Basal-like breast carcinoma: From expression profiling to routine practice. Arch Pathol Lab Med 2009;133:860-868.
57. Gusterson B. Do 'basal-like' breast cancers really exist? Nat Rev Cancer 2009;9:128-134.
58. Marhaba R, Zoller M. CD44 in cancer progression: Adhesion, migration and growth regulation. J Mol Histol 2004;35:211-231. (Pubitemid 40585308)
59. Sarrio D, Franklin CK, Mackay A et al. Epithelial and mesenchymal subpopulations within normal basal breast cell lines exhibit distinct stem cell/progenitor properties. Stem Cells 2012;30:292-303.
60. Pece S, Tosoni D, Confalonieri S et al. Biological and molecular heterogeneity of breast cancers correlates with their cancer stem cell content. Cell 2010;140:62-73.
61. Croker AK, Goodale D, Chu J et al. High aldehyde dehydrogenase and expression of cancer stem cell markers selects for breast cancer cells with enhanced malignant and metastatic ability. J Cell Mol Med 2009;13:2236-2252.
62. Zhang CC, Yan Z, Zhang Q et al. PF-03732010: A fully human monoclonal antibody against P-cadherin with antitumor and antimetastatic activity. Clin Cancer Res 2010;16:5177-5188.